1. Home
  2. KNSA vs OSW Comparison

KNSA vs OSW Comparison

Compare KNSA & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • OSW
  • Stock Information
  • Founded
  • KNSA 2015
  • OSW N/A
  • Country
  • KNSA United Kingdom
  • OSW Bahamas
  • Employees
  • KNSA N/A
  • OSW N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • OSW Hotels/Resorts
  • Sector
  • KNSA Health Care
  • OSW Consumer Discretionary
  • Exchange
  • KNSA Nasdaq
  • OSW Nasdaq
  • Market Cap
  • KNSA 1.7B
  • OSW 2.0B
  • IPO Year
  • KNSA 2018
  • OSW N/A
  • Fundamental
  • Price
  • KNSA $21.09
  • OSW $19.10
  • Analyst Decision
  • KNSA Strong Buy
  • OSW Strong Buy
  • Analyst Count
  • KNSA 5
  • OSW 4
  • Target Price
  • KNSA $36.60
  • OSW $18.75
  • AVG Volume (30 Days)
  • KNSA 365.7K
  • OSW 596.1K
  • Earning Date
  • KNSA 10-29-2024
  • OSW 10-30-2024
  • Dividend Yield
  • KNSA N/A
  • OSW 0.42%
  • EPS Growth
  • KNSA N/A
  • OSW 2284.58
  • EPS
  • KNSA N/A
  • OSW 0.50
  • Revenue
  • KNSA $384,098,000.00
  • OSW $872,619,000.00
  • Revenue This Year
  • KNSA $60.05
  • OSW $13.37
  • Revenue Next Year
  • KNSA $36.32
  • OSW $9.04
  • P/E Ratio
  • KNSA N/A
  • OSW $37.87
  • Revenue Growth
  • KNSA 54.41
  • OSW 13.60
  • 52 Week Low
  • KNSA $15.52
  • OSW $11.50
  • 52 Week High
  • KNSA $28.15
  • OSW $19.61
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 34.36
  • OSW 66.64
  • Support Level
  • KNSA $20.41
  • OSW $18.27
  • Resistance Level
  • KNSA $21.55
  • OSW $19.61
  • Average True Range (ATR)
  • KNSA 0.87
  • OSW 0.42
  • MACD
  • KNSA -0.14
  • OSW -0.03
  • Stochastic Oscillator
  • KNSA 21.90
  • OSW 76.61

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About OSW OneSpaWorld Holdings Limited

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts worldwide. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

Share on Social Networks: